Euro-Med Laboratories Phils Inc
Euro-Med Laboratories Phils Inc operates in Pharmaceuticals.
Euro-Med Laboratories Phils Inc (EURO) - Total Liabilities
Latest total liabilities as of December 2022: ₱4.35 Billion PHP
Based on the latest financial reports, Euro-Med Laboratories Phils Inc (EURO) has total liabilities worth ₱4.35 Billion PHP as of December 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Euro-Med Laboratories Phils Inc - Total Liabilities Trend (2014–2022)
This chart illustrates how Euro-Med Laboratories Phils Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Euro-Med Laboratories Phils Inc Competitors by Total Liabilities
The table below lists competitors of Euro-Med Laboratories Phils Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BRI AGRO
BE:0R8
|
Germany | €9.36 Trillion |
|
Big Gold Inc.
F:H7L
|
Germany | €270.41K |
|
Oncimmune Holdings plc
LSE:ONC
|
UK | GBX7.30 Million |
|
RISANAMENTO
MU:RN5
|
Germany | €136.32 Million |
|
Alsons Consolidated Resources Inc
PSE:ACR
|
Philippines | ₱34.74 Billion |
Liability Composition Analysis (2014–2022)
This chart breaks down Euro-Med Laboratories Phils Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Euro-Med Laboratories Phils Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Euro-Med Laboratories Phils Inc (2014–2022)
The table below shows the annual total liabilities of Euro-Med Laboratories Phils Inc from 2014 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | ₱4.35 Billion | +7.38% |
| 2021-12-31 | ₱4.05 Billion | -12.39% |
| 2020-12-31 | ₱4.62 Billion | -5.29% |
| 2019-12-31 | ₱4.88 Billion | +12.89% |
| 2018-12-31 | ₱4.32 Billion | +12.96% |
| 2017-12-31 | ₱3.83 Billion | -9.45% |
| 2016-12-31 | ₱4.23 Billion | +1.39% |
| 2015-12-31 | ₱4.17 Billion | -10.13% |
| 2014-12-31 | ₱4.64 Billion | -- |